AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Beximco Pharmaceuticals Limited

58.5p +$16.00 (+37.65%)
LSE · 16 Sep 2026 07:00 UTC
Previous Close
58.5p
Day Range
58.5p - 58.5p
Year Range
0.42p65p
Market Cap
260.98M
AVG Volume
76.12K
Trailing/Forward PE
6.33/5.86
PEG ratio
0.45
Dividend Yield
3.97%
Next Earnings Date
2026-12-02
Primary Exchange
London Stock ExchangeUK
Revenue (BDT) · TTM
020B40B60B22 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
BXP.L Revenue (BDT) · TTM by quarter
PeriodRevenue (BDT) · TTM
24 Q246.34B
24 Q144.95B
23 Q444.39B
23 Q343.08B
23 Q241.65B
23 Q140.64B
22 Q439.27B
22 Q337.97B
22 Q237.38B
22 Q135.99B
Net Income (BDT) · TTM
02B4B6B8B22 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
BXP.L Net Income (BDT) · TTM by quarter
PeriodNet Income (BDT) · TTM
24 Q26.35B
24 Q15.96B
23 Q45.83B
23 Q35.33B
23 Q24.92B
23 Q14.72B
22 Q44.61B
22 Q34.48B
22 Q24.63B
22 Q15.1B
Operating Income (BDT) · TTM
02.5B5B7.5B10B22 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
BXP.L Operating Income (BDT) · TTM by quarter
PeriodOperating Income (BDT) · TTM
24 Q29.22B
24 Q18.93B
23 Q48.57B
23 Q38.02B
23 Q27.57B
23 Q17.31B
22 Q47.22B
22 Q36.8B
22 Q27.05B
22 Q16.91B
EBITDA (BDT) · TTM
05B10B15B22 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
BXP.L EBITDA (BDT) · TTM by quarter
PeriodEBITDA (BDT) · TTM
24 Q210.21B
24 Q110.32B
23 Q410.07B
23 Q39.59B
23 Q29.27B
23 Q19.02B
22 Q49.04B
22 Q38.61B
22 Q28.87B
22 Q19.2B
Cash Flows (BDT) · TTM
02B4B6B8B22 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
BXP.L Cash Flows (BDT) · TTM by quarter
PeriodCash Flows (BDT) · TTM
24 Q23.97B
24 Q15.54B
23 Q46.34B
23 Q36.14B
23 Q24.88B
23 Q14.13B
22 Q42.7B
22 Q31.63B
22 Q21.3B
22 Q11.89B
EPS (BDT) · TTM
05101522 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
BXP.L EPS (BDT) · TTM by quarter
PeriodEPS (BDT) · TTM
24 Q214.24
24 Q113.35
23 Q413.06
23 Q311.95
23 Q211.02
23 Q110.58
22 Q410.34
22 Q310.03
22 Q210.37
22 Q111.44
Expenses (BDT) · TTM
05B10B15B20BR&DSG&ACapex22 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
BXP.L Expenses (BDT) · TTM by quarter
PeriodExpenses (BDT) · TTM
24 Q214.62B
24 Q113.38B
23 Q413.34B
23 Q313.31B
23 Q213.25B
23 Q113.29B
22 Q413.17B
22 Q316.16B
22 Q215.41B
22 Q115.35B
Dividends (BDT)
01234Oct 16Nov 17Nov 18Nov 19Nov 20Nov 21Nov 22Nov 23Nov 24Jul 26
BXP.L Dividends (BDT) by quarter
PeriodDividends (BDT)
Jul 262.32
Nov 243.35
Nov 233.17
Nov 223.32
Nov 213.97
Nov 201.77
Nov 191.13
Nov 181.26
Nov 171.24
Oct 160.6
Beximco Pharmaceuticals Limited
BXP.L
Stockpicker

Video analysis: BXP.L

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.